Table 2—

Treatment effects for HbA1c

Mean HbA1c(%)
Treatment effect (adjusted for baseline HbA1c)
CSII groupMDI groupCSII − MDI95% CIP
Baseline (months)7.738.16
17.427.760.08(−0.19, 0.35)>0.10
27.067.490.00(−0.34, 0.35)>0.10
36.927.55−0.21(−0.59, 0.17)>0.10
47.077.51−0.01(−0.42, 0.39)>0.10
57.167.400.18(−0.24, 0.60)>0.10
67.197.62−0.01(−0.44, 0.42)>0.10
77.327.560.18(−0.25, 0.61)>0.10
87.267.440.24(−0.19, 0.68)>0.10
97.387.560.25(−0.19, 0.68)>0.10
  • Note: absolute values for HbA1c are shown in both CSII and MDI groups. The treatment effect, namely CSII − MDI corrected for baseline differences, is shown. At no time point were there any clinically significant differences.